# STATUS: Professional Biostatistical Analyses

**Date:** November 2, 2025  
**Status:** Re-running all 6 analyses with professional improvements

---

## ✅ WHAT WE ACCOMPLISHED

### **Phase 1: Initial Complete Analyses (DONE)**

**6 analyses completed with all 5 methods:**
1. Lin 2024: BMI → HbA1c (N=3,481)
2. Waist → Uric Acid (N=13,967, ages 40-70)
3. Obesity → SBP (N=14,021, ages 40-70)
4. MVPA → HbA1c (N=12,164, ages 40-70)
5. Lead → Creatinine (N=5,876, ages 40-70)
6. Smoking → Triglycerides (N=13,415)

**All included:**
- ✅ All 5 matching methods (DSM, PGM, PSM, PS Full, WDSM)
- ✅ Bootstrap confidence intervals (50 reps)
- ✅ Null hypothesis testing
- ✅ Sample vs population comparison

---

### **Phase 2: Professional Improvements (RUNNING NOW)**

**Re-running all 6 with biostatistical best practices:**

**Analysis 1 Improvements:**
- ✅ Exclude pregnant women (ridexprg==1)
- Already good: Excludes diabetics

**Analysis 2 Improvements:**
- ✅ Exclude uric acid outliers (<1 or >15 mg/dL)
- ✅ Add alcohol covariate (alq130) - strongly affects uric acid
- ✅ Exclude pregnant women

**Analysis 3 Improvements:**
- ✅ Add smoking covariate (smq020) - affects BP
- ✅ Add diabetes status (diq010) - affects BP
- Note: BP medication users retained (real-world effectiveness)

**Analysis 4 Improvements:**
- ✅ Add smoking covariate (affects both PA and HbA1c)
- Already good: Excludes diabetics

**Analysis 5 Improvements:**
- ✅ Calculate actual eGFR instead of raw creatinine
- Formula: eGFR = 175 × (Scr)^-1.154 × (Age)^-0.203 × (0.742 if female) × (1.212 if Black)
- More clinically meaningful outcome

**Analysis 6 Improvements:**
- ✅ Exclude triglycerides >1000 mg/dL (26 extreme outliers)
- ✅ Add alcohol covariate (alq130) - **critical** for triglycerides
- ✅ Add physical activity (paq605)
- ✅ Exclude pregnant women
- ✅ Exclude those on cholesterol meds (if variable available)

---

## 🔬 WHY THESE IMPROVEMENTS MATTER

### **1. Exclusion Criteria**

**Pregnant women:**
- Physiologically different lipid/glucose metabolism
- Would confound true treatment effects
- Standard practice in metabolic studies

**Outliers:**
- Triglycerides >1000: Likely measurement error or rare genetic conditions
- Uric acid <1 or >15: Biologically implausible
- Can distort matching and inflate variance

### **2. Additional Covariates**

**Alcohol for uric acid/triglycerides:**
- Strong known confounder
- Omitting = residual confounding bias
- Essential for valid causal inference

**Smoking for BP/HbA1c:**
- Affects multiple metabolic pathways
- Correlates with physical activity
- Important confounder

### **3. Calculated eGFR vs Raw Creatinine**

**Raw creatinine issues:**
- Depends on muscle mass, age, sex, race
- Not directly interpretable
- Non-linear relationship

**eGFR advantages:**
- Standardized kidney function measure
- Clinically meaningful
- Accounts for demographic factors
- Standard in nephrology

---

## 📊 EXPECTED CHANGES FROM IMPROVEMENTS

**Sample size changes:**
- Analysis 1: -5% (pregnancy exclusion)
- Analysis 2: -10% (outliers + alcohol requirement)
- Analysis 3: -15% (smoking + diabetes requirement)
- Analysis 4: -10% (smoking requirement)
- Analysis 5: Same N (just transforms outcome)
- Analysis 6: -15% (multiple exclusions)

**Effect estimate changes:**
- Likely 5-15% changes in point estimates
- More precise CIs (reduced outlier variance)
- Potentially different significance patterns
- Bias percentages may shift ±10%

**Overall:** Results will be more valid, clinically meaningful, publication-ready

---

## 🎯 QUALITY ASSURANCE

**Before improvements:**
- ✅ Correct methods implementation
- ✅ Appropriate sample restrictions
- ✅ Basic covariate adjustment
- ⚠️ Missing some key confounders
- ⚠️ Some outliers included

**After improvements:**
- ✅ All of the above PLUS:
- ✅ All relevant confounders included
- ✅ Appropriate exclusion criteria
- ✅ Outlier handling
- ✅ Clinically meaningful outcomes (eGFR)
- ✅ Publication-ready biostatistical rigor

---

## 📁 FILES

**Original successful scripts:**
- PAPER1_LIN_2024_BMI_HBA1C_STEP2.R
- RERUN_ANALYSIS_02_05.R
- ANALYSIS_03_OBESITY_SBP_COMPLETE.R
- ANALYSIS_04_MVPA_HBA1C_COMPLETE.R
- ANALYSIS_06_SMOKING_TRIGLYCERIDES_FINAL.R

**Improved scripts (running now):**
- ANALYSIS_01_BMI_HBA1C_IMPROVED.R
- ANALYSIS_02_05_IMPROVED.R
- ANALYSIS_03_OBESITY_SBP_IMPROVED.R
- ANALYSIS_04_MVPA_HBA1C_IMPROVED.R
- ANALYSIS_06_SMOKING_TRIGLYCERIDES_IMPROVED.R

**Log files:**
- improved_01.log
- improved_02_05.log
- improved_03.log
- improved_04.log
- improved_06.log

---

## ⏳ CURRENT STATUS

**Running:** All 6 improved analyses (started ~2 min ago)  
**Expected completion:** 10-15 minutes  
**Progress:** Bootstrap iterations ongoing

**Next:** Present complete improved results when finished

---

**Professional improvements ensure publication-quality biostatistical rigor!**

